Displaying drugs 14451 - 14475 of 15056 in total
EMI-137
EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).
Investigational
Dapiglutide
Dapiglutide is under investigation in clinical trial NCT05788601 (Dapiglutide for the Treatment of Obesity).
Investigational
Onvitrelin ucalontide
Onvitrelin ucalontide is under investigation in clinical trial NCT01485848 (EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer).
Investigational
Atexakin alfa
Atexakin alfa is under investigation in clinical trial NCT05435742 (SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)).
Investigational
Lixudebart
Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.
Investigational
Bos taurus colostrum
Investigational
Ecklonia cava
Investigational
Stapuldencel
Investigational
Pseudomonas aeruginosa
Investigational
Cancer/testis antigen 1
Investigational
Human placenta hydrolysate
Investigational
Interleukin-12 human recombinant
Investigational
Bemiltenase alfa
Investigational
ION356
Investigational
BV2
Experimental
3h-Indole-5,6-Diol
Experimental
Xylose-derived lactam oxime
Experimental
3-Methylpyridine
Experimental
D-gluconhydroximo-1,5-lactam
Experimental
Hydrogenobyrinic acid
Experimental
Indirubin-5-sulphonate
Experimental
Siroheme
Experimental
2-Acetyl-Protoporphyrin Ix
Experimental
IC261
Experimental
Displaying drugs 14451 - 14475 of 15056 in total